Item 5. Other Information

Securities Trading Plans of Directors and Executive Officers

During our last fiscal quarter, the following directors and officer, as defined in Rule 16a-1(f), adopted a “Rule 10b5-1 trading arrangement” as defined in Regulation S-K Item 408, as follows:

On March 14, 2024, Kenneth Duda, our Chief Technology Officer, Senior Vice President, Software Engineering and Director, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 480,000 shares of our common stock held in various trusts for the benefit of Mr. Duda’s family, for which Mr. Duda is the beneficial owner and which is intended to be treated as a single plan. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until June 16, 2025, or earlier if all transactions under the trading arrangement are completed.

On March 13, 2024, Anshul Sadana, our Chief Operating Officer, modified his Rule 10b5-1 trading arrangement previously adopted on December 14, 2023 providing for the sale from time to time of an aggregate of up to 126,861 shares of our common stock to reduce the aggregate number of shares of our common stock to up to 110,172 to reflect reduced vesting of previously issued grants due to Mr. Sadana’s previous leave of absence, which was announced February 16, 2024. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until June 12, 2025, or earlier if all transactions under the trading arrangement are completed. On April 18, 2024, Anshul Sadana notified us of his intention to resign from the Company, effective May 21, 2024.

On March 13, 2024, Daniel Scheinman, a member of our Board of Directors, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of 1,000 shares of our common stock. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until June 16, 2025, or earlier if all transactions under the trading arrangement are completed.

No other officers or directors, as defined in Rule 16a-1(f), adopted or terminated a “Rule 10b5-1 trading arrangement or a “non-Rule 10b5-1 trading arrangement,” as defined in Regulation S-K Item 408, during the last fiscal quarter.